Elsevier

The Lancet

Volume 316, Issue 8207, 13 December 1980, Pages 1276-1277
The Lancet

AMINOACID THERAPY OF ALCOHOLIC HEPATITIS

https://doi.org/10.1016/S0140-6736(80)92338-7Get rights and content

Abstract

35 consecutive patients with alcoholic hepatitis were randomly allocated to control (18 patients) and study (17 patients) groups. All patients were offered a 3000 kcal 100 g protein diet and were studied for 28 days. The study group received 70-85 g of intravenous aminoacids daily in the form of 'Aminosyn' or 'Travasol'. Both groups had similar clinical and biochemical features at the time of randomisation. Ascites and encephalopathy tended to improve more in the study group. Serum concentrations of bilirubin (p<0·01) and albumin (p<0·025) improved in the study but not in the control group. 4 patients died in the control group, but none died in the study group. Intravenous therapy with aminoacid for 4 weeks seemed to be associated with lower mortality rate (p<0·02) and improved serum bilirubin and albumin concentrations in patients with alcoholic hepatitis.

References (10)

There are more references available in the full text version of this article.

Cited by (136)

  • Nutrition in liver disease

    2023, Comprehensive Guide to Hepatitis Advances
  • ESPEN guideline on clinical nutrition in liver disease

    2019, Clinical Nutrition
    Citation Excerpt :

    In the most recent multicenter study, irrespective of treatment, lower calorie intake (21.5 kcal × kg−1 × d−1) was associated with worse clinical outcomes [113,184]. Calorie intake is significantly reduced even in the abstinent ASH patients, and increased caloric intake improves outcomes [110,185], but there are no randomized controlled trials directly comparing supplemental nutrition alone and ad lib oral intake only that support improved survival for additional nutrition. Whether the reduced caloric intake results in or contributes to the higher mortality in those patients achieving only a lower caloric intake or whether the reduction in spontaneous intake is an outcome of underlying necroinflammatory responses that contribute to higher mortality is not known and should be part of future evaluations.

  • Prevention and Management of Alcoholic Liver Disease

    2017, Zakim and Boyer's Hepatology: A Textbook of Liver Disease
  • Nutrition and Alcoholic Liver Disease: Effects of Alcoholism on Nutrition, Effects of Nutrition on Alcoholic Liver Disease, and Nutritional Therapies for Alcoholic Liver Disease

    2016, Clinics in Liver Disease
    Citation Excerpt :

    Pharmacotherapy has been of limited success in ensuring abstinence, but a multidisciplinary approach should be part of improving the diet, calorie and protein intake, and reversing sarcopenia. Several clinical trials and a meta-analysis have been published to date on nutritional support in cirrhosis in general and ALD in particular.18,20,36,75,77,78 These studies have not been conclusive despite large numbers of patients studied.

View all citing articles on Scopus
View full text